Clinical Trial Update: Platelet Rich Plasma in Corneal Surface Diseases [Phase 3]

View source ↗

Summary

Clinical trial update for platelet-rich plasma in corneal surface diseases (Phase 3) with conditions including persistent corneal epithelial defects and dry eye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Persistent Corneal Epithelial Defects

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Assiut University | Conditions: Persistent Corneal Epithelial Defects, Dry Eye | Phase 3 | Status: UNKNOWN